
Peter-Paul Zwetsloot
@ppmzwetsloot
MD, PhD, Epidemiologist. cardiologist and translational researcher @ErasmusMC. coordinator Dutch Cardiomyopathy Database
ID: 972754208
26-11-2012 21:34:29
145 Tweet
109 Followers
231 Following

#CochraneDaily 🎧 PODCAST🎧In 4 min learn from Peter-Paul Zwetsloot of University Medical Centre Utrecht about 3rd update of The Cochrane Library Review of stem cells for myocardial infarction: high certainty evidence of lack of important benefits UMC Utrecht cochrane.org/podcasts/10.10…




🙋♀️ Join our Fall event in Utrecht on Nov 22nd about career perspectives. What is your next step❓Young@Heart Anke Smits UMCG Cardiology Research Institute Peter-Paul Zwetsloot ➡️ Register here: young.heart-institute.nl/events/


Michelle Michels presenting the current thinking around genotype-positive phenotype-negative HCM #hcmsummit8 The International HCM Summit


Steve Ommen, MD 7/ Clinical Pearl 🦪 - Obstruction begets diastolic dysfunction” 💕 ⬆️ LV filling pressures -> Coronary perfusion -> ischemia🩸-> diastolic dysfunction -> ⬆️ LA pressures -> LV filling pressures


Exercise in patients with HCM is beneficial 🏃♀️🏋️♂️🫀Matthew W Martinez International HCM Summit 9 CardioNerds #HCMSummit8


Vandaag om 17.40 uur aandacht voor erfelijke hartziekten en het belang van opsporen in Tijd voor MAX cardiogenetica maxvandaag.nl/programmas/tv/…

Pearls from the keynote on #nextsteps by diederikgommers at the @YounAtHeartNL fall event 🍂 🍁 be authentic 🍁 be empathetic 🍁 communicate a positive message 🍁 add value from your expertise





SEQUOIAHCM: Effect of aficamten treatment on patients with hypertrophic obstructive cardiomyopathy by geographical region discussed by Caroline Coats & Brenda Moura Hosted by Peter-Paul Zwetsloot Watch their #HFASnacks 🤗 #HFA_ESC #HeartFailure2025 HFAPresident
